Cataract Clinical Trials 2024

What are the top hospitals conducting cataract research?

When it comes to advancing the treatment of cataracts, several hospitals across different locations are leading the way in groundbreaking clinical trials. In Brecksville, Ohio, the Cleveland Eye Clinic is making significant strides with three active cataract trials and a total of 12 past trials dedicated to this condition. Since recording their first trial in 2010, they have been at the forefront of cataract research, pursuing innovative approaches to improve patient outcomes. Similarly committed to pushing boundaries is Virginia Eye Consultants in Norfolk. With three ongoing cataract trials and eight completed studies since their inaugural trial in 2003, this hospital showcases a strong dedication to finding new solutions for cataract patients.

In San Antonio, Texas, Focal Point Vision has also emerged as a prominent player in advancing cataract treatments through its participation in three active clinical trials and ten previously conducted investigations since initiating their first trial only a decade ago in 2011.Their relentless pursuit of knowledge continues to shape future possibilities for those affected by this common vision impairment.In Sioux Falls,Vance Thompson Vision stands out with two active cataract trials and an impressive history of fourteen prior experiments dating back from their commencement on such endeavors starting year 2011.Meeting them on similar grounds yet earlier timeline-wise; The Eye Institute Of West Florida from Largo holds two current ongoing tests besides contributing significantly through six preconceived endeavors about handling said cases- beginning as early as twenty years ago (in2002); ensuring that accumulated experience results further refining techniques

These hospitals exemplify both commitment and progress when it comes to fighting against cataracts —a condition that affects millions worldwide— offering hope not just for improved visual health but also for advancements within ophthalmology as a whole. Together they represent beacons illuminating paths towards better understanding while providing assurance that continued efforts will ultimately lead us closer to more effective treatments for individuals suffering from vision loss due t ocular conditions

Which are the best cities for cataract clinical trials?

When it comes to cataract clinical trials, several cities have emerged as leaders in research and innovation. Houston, Texas leads the way with 10 active trials focusing on advancements such as phacoemulsification surgery, light adjustable lens (LAL) and light delivery device (LDD), smaller incisions, and new generation implantable miniature telescopes. San Antonio, Texas closely follows with 6 ongoing studies exploring investigational healon endocoat, investigational lens devices, LAL and LDD technologies. New york City joins the ranks with 5 active trials investigating interventions using patient navigators, astigmatism correction techniques, and dexamethasone applications. Mount Pleasant, South carolina also has 5 active trials examining topics like phacoemulsification surgery and contralateral implantation of various IOLs. Saint Louis Missouri rounds out the list with its focus on ripasudil applications for cataracts along with other treatment options like iStent and Dextenza. These cities provide individuals seeking cataract treatments access to cutting-edge clinical trials that contribute to advancing care for this common eye condition.

Which are the top treatments for cataract being explored in clinical trials?

Cataract treatment research is making strides in clinical trials, with several promising options currently being explored. Leading the pack is Dextenza, which is undergoing three active trials and was first listed in 2020. Not far behind is dexamethasone, with two ongoing trials and a history of 12 all-time cataract studies since its introduction in 2013. Additionally, BSS Plus has shown potential as it undergoes one active trial and has been part of three all-time cataract trials since its listing in 2004. These innovative treatments offer hope for improved outcomes for patients dealing with cataracts.

What are the most recent clinical trials for cataract?

Recent clinical trials in the field of cataract research offer promising advancements for patients seeking improved treatment options. One such trial investigates the efficacy of Omega-3 supplements in managing cataracts, with Phase 4 results indicating potential benefits. Another study focuses on interventions specifically designed to address cataract progression and explore novel approaches towards its management. Additionally, a Phase 4 trial explores the outcomes of cataract surgery when combined with Dextenza and a reduced frequency of eye drop regimen—a potential game-changer for post-operative care. Furthermore, ongoing Phase 3 trials are evaluating K-321 as a possible treatment option for individuals with cataracts, while another Phase 4 trial examines the suitability of BSS Plus in enhancing surgical outcomes. These groundbreaking studies pave the way for exciting developments in addressing this common visual impairment.

What cataract clinical trials were recently completed?

Several recent clinical trials have reached completion, contributing to advancements in cataract treatment. In March 2021 and January 2021, Formosa Pharmaceuticals successfully concluded trials for APP13007 at a concentration of 0.05%. Additionally, PolyActiva Pty Ltd wrapped up their trial for Levofloxacin Ocular Implant in January 2021. These studies were followed by Loma Linda University's trial investigating Hypochlorous Acid Gel at a concentration of 0.02%, completed in October 2020, and The New york Eye Surgery Center's study on Dexamethasone Ophthalmic Insert finished in January 2020. By pushing the boundaries of research and innovation, these clinical trials provide valuable insights into potential treatments for cataracts—a significant cause of visual impairment worldwide.